TH-103

N/A

Report date: 2024/12/06 14:39:41

Base Information

Drug NameTH-103
Drug Alias NameTH-103TH103
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-Vascular endothelial growth factor
TargetsVascular endothelial growth factor
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKalaris Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKalaris Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A